Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Differential regulation of HIF-alpha paralogs via CDK8
EF 2023-24
Résumé
Many organisms require oxygen to survive because cells use oxygen to efficiently produce energy. Due to the importance of oxygen, proteins that detect changes in the levels of environmental oxygen evolved over time. Two examples of such proteins are the hypoxia-inducible factor subunits 1 alpha (HIF1?) and 2 alpha (HIF2?). Sufficient oxygen levels cause HIF1? and HIF2? to be destroyed, but low oxygen levels (also termed hypoxia) prevent this destruction. Instead, HIF1? and HIF2? bind to a beta subunit (HIF?). Subsequently, HIF1? and HIF2? activate genes that allow the cell to adapt to hypoxia. Scientists have suggested that HIF1? suppresses and HIF2? promotes clear cell renal cell carcinoma (ccRCC), the most common kidney cancer type. However, their roles in ccRCC remain unclear, so uncovering the differences between HIF1? and HIF2? at the molecular level will enhance our understanding of ccRCC. I have shown that HIF1?, but not HIF2?, is modified via phosphorylation upon binding to HIF?. Interestingly, cyclin-dependent kinase 8 (CDK8) is found in regions of DNA where HIF1?, but not HIF2?, is also found. Therefore, we hypothesize that, upon binding to HIF?, CDK8 phosphorylates HIF1?, but not HIF2?, thereby contributing to the activity of HIF1?. To test this, I first aim to identify the location of HIF1? phosphorylation when it binds to HIF?. Doing so will allow for future exploration of how this phosphorylation affects the function of HIF1?. Second, I aim to determine if CDK8 phosphorylates HIF1? but not HIF2?. This will enhance our understanding of the different molecular mechanisms that regulate HIF1? and HIF2?. My research will help us understand why HIF1? and HIF2? play opposing roles in ccRCC, as well as help us develop treatments that specifically target HIF1?.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
506016
Name
Eo Jeffrey J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Differential regulation of HIF-alpha paralogs via CDK8
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cell Signaling; Clear Cell Renal Cell Carcinoma; Hypoxia; Hypoxia-Inducible Factor; Von Hippel-Lindau Disease
Abstract
Many organisms require oxygen to survive because cells use oxygen to efficiently produce energy. Due to the importance of oxygen, proteins that detect changes in the levels of environmental oxygen evolved over time. Two examples of such proteins are the hypoxia-inducible factor subunits 1 alpha (HIF1?) and 2 alpha (HIF2?). Sufficient oxygen levels cause HIF1? and HIF2? to be destroyed, but low oxygen levels (also termed hypoxia) prevent this destruction. Instead, HIF1? and HIF2? bind to a beta subunit (HIF?). Subsequently, HIF1? and HIF2? activate genes that allow the cell to adapt to hypoxia. Scientists have suggested that HIF1? suppresses and HIF2? promotes clear cell renal cell carcinoma (ccRCC), the most common kidney cancer type. However, their roles in ccRCC remain unclear, so uncovering the differences between HIF1? and HIF2? at the molecular level will enhance our understanding of ccRCC. I have shown that HIF1?, but not HIF2?, is modified via phosphorylation upon binding to HIF?. Interestingly, cyclin-dependent kinase 8 (CDK8) is found in regions of DNA where HIF1?, but not HIF2?, is also found. Therefore, we hypothesize that, upon binding to HIF?, CDK8 phosphorylates HIF1?, but not HIF2?, thereby contributing to the activity of HIF1?. To test this, I first aim to identify the location of HIF1? phosphorylation when it binds to HIF?. Doing so will allow for future exploration of how this phosphorylation affects the function of HIF1?. Second, I aim to determine if CDK8 phosphorylates HIF1? but not HIF2?. This will enhance our understanding of the different molecular mechanisms that regulate HIF1? and HIF2?. My research will help us understand why HIF1? and HIF2? play opposing roles in ccRCC, as well as help us develop treatments that specifically target HIF1?.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Eo, Jeffrey J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~